Summary Digna Biotech SL (Digna) is a biotechnology company that specializes in the development and commercialization of robust clinical therapeutic candidates. The company’s pipeline portfolio includes cutaneous manifestation of scleroderma, clinical indications for kidney transplant and liver surgery, gene therapy acute intermittent prophyria and hepatitis C virus infection. Its preclinical product portfolio comprises Ischemic stroke, anti-tumor antibodies increasing antibody-dependent cell-mediated cytotoxicity against malignant cells, indications liver cirrhosis, blood loss, and liver-targeted fusion protein for treatment of cancer, and others. Digna’s therapeutic expertise includes dermatology, cardiovascular, oncology, liver diseases, and others. The company has its presence in Madrid and the US. Digna is headquartered in Pamplona, Spain.
Digna Biotech SL - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope - Financial Deals - Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. - Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. - Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. - Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. - Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector. - Major Deals - Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios. - Business Description - A brief description of the company’s operations. - Key Employees - A list of the key executives of the company. - Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company. - Key Competitors - A list of the key competitors of the company. - Key Recent Developments - A brief on recent news about the company.
Reasons to Buy Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements - The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy - The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers. - The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Our reports have been used by over 10K customers, including:
120 pages •
By Infiniti Research Limited
• Jan 2021
Global VOC gas monitor market 2021-2025
The analyst has been monitoring the VOC gas monitor market and it is poised to grow by $ 50.05 mn during 2021-2025, progressing at a CAGR of 5% during the forecast period. Our report on VOC gas monitor market provides a holistic analysis, market size and forecast, trends, growth...
Active Pharmaceutical Ingredients (API) Market Report Overview Active Pharmaceutical Ingredients (API) market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Active Pharmaceutical Ingredients (API) market types and applications. It is a focused...
The Quantum Computing market is expected to grow from USD 472 million in 2021 to USD 1,765 million by 2026, at a CAGR of 30.2%. The early adoption of quantum computing in the banking and finance sector is expected to fuel the growth of the market globally. Other key factors contributing to the growth of the quantum computing market include...
The global contract lifecycle management software market reached a value of US$ 1.51 Billion in 2020. Contract lifecycle management (CLM) software assists in efficiently managing the complete process of a contract signed between two or more organizations. It comprises of eight vital steps: contract drafting, negotiation, approval, compliance...
In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global IV and Oral Iron Drugs Market Report
The global IV and oral iron drugs market by revenue is expected to grow at a CAGR of 11.6% during the period 2021–2026.
The global IV and oral iron drugs market is expected to grow due to the prevalence...
The global blister packaging market reached a value of US$ 21.3 Billion in 2020. Blister packaging refers to a pre-formed plastic packaging which comprises of a cavity that is made using a thermoformed plastic and a paper or aluminum foil back. This type of packaging displays a large part of the content to consumers while protecting it from...
The cooler box market is estimated to be valued at USD 4.6 billion in 2020 and is projected to reach USD 8.1 billion by 2025, at a CAGR of 12.1% from 2020 to 2025 Growth in the pharmaceutical industry, ongoing COVID-19 vaccination drives, transportation of processed and fresh fruits, vegetables, dairy products, and other perishable food products...
120 pages •
By Infiniti Research Limited
• Jan 2021
Global Powered Air Purifying Respirator Market 2021-2025
The analyst has been monitoring the powered air purifying respirator market and it is poised to grow by $ 638.16 mn during 2021-2025 progressing at a CAGR of 6% during the forecast period. Our report on powered air purifying respirator market provides a holistic...
The South and Central America medical writing market is expected to reach US$ 362.35 million by 2027 from US$ 217.01 million in 2019; it is anticipated to grow at a CAGR of 6.6% from 2020-2027. The growth of South and Central America medical writing market is driven by the rising government support to the healthcare sector and increasing...
The global high-performance liquid chromatography (HPLC) market grew at a CAGR of around 6% during 2014-2019. High-performance liquid chromatography (HPLC) refers to the chromatographic technique of separating different compounds from a mixture. The technique uses a glass reservoir to hold the solution, numerous pumps...
Pharmaceutical
Research And Development
World
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.